(Q38193300)

30 August 2017

1 reference

title

Prostate cancer in Asian men. (English)

1 reference

30 August 2017

1 reference

Kazuto Ito

1

1 reference

PubMed ID

24595118

30 August 2017

language of work or name

English

0 references

publication date

4 March 2014

1 reference

30 August 2017

Nature Reviews Urology

1 reference

30 August 2017

11

1 reference

30 August 2017

4

1 reference

30 August 2017

197-212

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2014.42

30 August 2017

0 references

cites work

Cancer incidence and incidence rates in Japan in 2004: based on data from 14 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Cancer trends and incidence and mortality patterns in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

A cancer incidence survey in Tianjin: the third largest city in China-between 1981 and 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Cancer trends and incidences in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

International variation in prostate cancer incidence and mortality rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

The burden of prostate cancer in Asian nations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Cancer statistics in Korea: incidence, mortality and survival in 2006-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Oncological outcomes of the prostate cancer patients registered in 2004: report from the Cancer Registration Committee of the JUA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Epidemiology of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

An overview of prostate diseases and their characteristics specific to Asian men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

International trends and patterns of prostate cancer incidence and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Prostate cancer: an emerging threat to the health of aging men in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Trends in mortality from cancers of the breast, colon, prostate, esophagus, and stomach in East Asia: role of nutrition transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Heterogeneity in genetic susceptibility to prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Genomewide linkage analysis of familial prostate cancer in the Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Role of squalene synthase in prostate cancer risk and the biological aggressiveness of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Plasma isoflavones and subsequent risk of prostate cancer in a nested case-control study: the Japan Public Health Center

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Impact of race and baseline PSA on longitudinal PSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Relationship among initial serum prostate specific antigen, prostate specific antigen progression and prostate cancer detection at repeat screening visits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Changes in baseline PSA levels in Japanese men from 1988 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Ethnic differences in distribution of serum prostate-specific antigen: a study in a healthy Chinese male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Ethnic differences in the age-related distribution of serum prostate-specific antigen values: a study in a healthy Korean male population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Distribution of serum prostate-specific antigen in healthy Korean men: influence of ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Age-specific reference ranges for prostate-specific antigen (PSA) in Jordanian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Prostate cancer screening in a Saudi population: an explanatory trial study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Age-specific reference levels of serum prostate-specific antigen and prostate volume in healthy Arab men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Development and external validation of a nomogram for predicting cancer probability at initial prostate biopsy using the life expectancy- and prostate volume-adjusted biopsy scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Prostate cancer in Taiwan: epidemiology and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Management of prostate cancer in China: a multicenter report of 6 institutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Clinical characteristics of prostate cancer in Japanese men in the eras before and after serum prostate-specific antigen testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Prostate-cancer mortality at 11 years of follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Comparison of the clinical outcome after hormonal therapy for prostate cancer between Japanese and Caucasian men

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

A Joinpoint regression analysis of long-term trends in cancer mortality in Japan (1958-2004)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Geographic pathology of latent prostatic carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Study of Latent Carcinoma of the Prostate in the Japanese Based on Necropsy Material

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Comparative Study of Latent Carcinoma of the Prostate Among Japanese in Japan and Hawaii 2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

CAG polymorphic repeat lengths in androgen receptor gene among Japanese prostate cancer patients: potential predictor of prognosis after endocrine therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Association of SNP rs1447295 and microsatellite marker DG8S737 with familial prostate cancer and high grade disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Effectiveness of mass screening for the prognosis of prostate cancer patients in Japanese communities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2014.42

Cancer incidences in urban Delhi - 2001-05.

31 March 2020

1 reference

12 December 2020

Hereditary prostate cancer: epidemiologic and clinical features

1 reference

12 December 2020

Cancer epidemiology in South Asia - past, present and future

1 reference

12 December 2020

Cancer epidemiology in mainland South-East Asia - past, present and future

1 reference

12 December 2020

Singapore cancer trends in the last decade

1 reference

12 December 2020

Prostate-specific antigen levels among Chinese, Malays and Indians in Singapore from a community-based study

1 reference

12 December 2020

Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008.

1 reference

12 December 2020

Role of PSA testing in multiphasic health screening

1 reference

12 December 2020

Cancer epidemiology in South-West Asia - past, present and future

1 reference

12 December 2020

Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis

1 reference

12 December 2020

Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men.

1 reference

12 December 2020

Cancer in Asia - Incidence rates based on data in cancer incidence in five continents IX (1998-2002).

1 reference

12 December 2020

Trends in cancer incidence in Chennai city (1982-2006) and statewide predictions of future burden in Tamil Nadu (2007-16).

1 reference

12 December 2020

Incidence, mortality and five-year relative survival ratio of prostate cancer among Chinese residents in Singapore from 1968 to 2002 by metastatic staging

1 reference

12 December 2020

Cancer epidemiology and control in North-Western and Central Asia - past, present and future.

1 reference

12 December 2020

Cancer incidence and mortality in Mongolia - National Registry Data.

1 reference

12 December 2020

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

1 reference

12 December 2020

Epidemiology of prostate cancer in United Arab Emirates.

1 reference

12 December 2020

Toward prostate cancer early detection in Iran

1 reference

12 December 2020

Cancer epidemiology and control in north-East Asia - past, present and future.

1 reference

12 December 2020

Cancer incidence rates in Turkey in 2006: a detailed registry based estimation

1 reference

12 December 2020

Cancer epidemiology and control in peninsular and island South-East Asia - past, present and future

1 reference

12 December 2020

Histopathological analysis of latent prostatic carcinoma in Japan

1 reference

12 December 2020

A comparative study of prostate cancer detection and management in China and in France.

1 reference

12 December 2020

Mass screening of 12,027 elderly men for prostate carcinoma by measuring serum prostate specific antigen

1 reference

12 December 2020

A p53 codon 72 polymorphism associated with prostate cancer development and progression in Japanese

1 reference

12 December 2020

Distribution of serum prostate-specific antigen in Chinese healthy men: a population-based study.

1 reference

12 December 2020

Cancer registration in Basrah 2005: preliminary results.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2014.42

1 reference

PubMed ID

24595118

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24595118